Given the observed clustering of obesity, hypertension, inflammation, intermittent hypoxia, hyperglycemia, and insulin and leptin resistance, studies in humans in this area are extremely difficult and require innovative experimental approaches. This evidence concerns the gene LEP and hypertensive disorder.